Inhibikase Therapeutics, Inc. (NASDAQ:IKT) has 73 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 230,388 | 7.49% | $0.00 |
| Blackstone Inc. | 31 Dec, 2025 | 0 | 3,300,000 | 125.08% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 10,880,295 | 207.34% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | 9,217 | 10.77% | $0.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Sands Capital Alternatives, LLC | 31 Dec, 2025 | 0 | 2,068,965 | 18.89% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,285,265 | 39.26% | $0.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 0 | 4,550,000 | 71.94% | $0.00 |
| Nantahala Capital Management, LLC | 31 Dec, 2025 | 0 | 1,739,292 | 79.42% | $0.00 |
| Fairmount Funds Management LLC | 31 Dec, 2025 | 0 | 2,500,000 | 40.82% | $0.00 |
| Stonepine Capital Management, LLC | 31 Dec, 2025 | 0 | 1,613,128 | 219.47% | $0.00 |
| Trails Edge Capital Partners, LP | 31 Dec, 2025 | 0 | 6,178,124 | 0.00% | $0.00 |
| Ameriprise Financial Inc | 31 Dec, 2025 | 0 | 1,376,395 | 0.00% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | 5,850,000 | 0.00% | $0.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 0 | 1,171,960 | 1,635.22% | $0.00 |
| Commodore Capital LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 15,665 | 1.41% | $0.00 |
| Squadron Capital Management LLC | 31 Dec, 2025 | 0 | 4,225,000 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 47,100 | 9.28% | $0.00 |
| Saturn V Capital Management LP | 31 Dec, 2025 | 0 | 3,856,799 | 0.00% | $0.00 |